Anogen - Yes Biotech Laboratories Ltd.

Anogen is the leader among biopharmaceutical product manufacturers. Our mission is dedicated to supply the best quality of antibodies and ELISA Kits worldwide.

[Anogen - Yes Biotech Laboratories Ltd. @AnogenYes]

🔬 Anti-IL-8 antibodies continue to emerge as promising therapeutic candidates across oncology and inflammatory diseases.

Reference:
BMS-986253 / HuMax-IL8 Phase I trial (PubMed), https://t.co/WqVQ5eV3p5

#Anogen #IL8 #Immunology #AntibodyTherapy #CancerResearch #Endometriosis

[Anogen - Yes Biotech Laboratories Ltd. @AnogenYes]

🧠 New research highlights the potential role of immunotherapy in healthy brain aging.

🔗 Read more: https://t.co/raJeawDtg7

#Anogen
#Neuroscience #Neuroinflammation #BrainHealth #Immunology #AgingResearch #Biotech #MonoclonalAntibodies #CognitiveHealth

[Anogen - Yes Biotech Laboratories Ltd. @AnogenYes]

Tiziana Life Sciences recently reported reduced brain inflammation in patients with non-active secondary progressive multiple sclerosis (SPMS) treated with intranasal foralumab, an investigational anti-CD3 monoclonal antibody therapy.

🔗 Read more: https://t.co/tT5kK5gFo4

[Anogen - Yes Biotech Laboratories Ltd. @AnogenYes]

🧠 Vitamin D May Play a Bigger Role in Brain Health Than We Thought Recent research continues to highlight the connection between vitamin D deficiency and increased risk of cognitive decline, dementia, and Alzheimer’s disease.

🔗 Read more: https://t.co/YQwjTq0P1q

#Anogen

[Anogen - Yes Biotech Laboratories Ltd. @AnogenYes]

Anti-IL-17A Therapies Continue to Expand Across Immunology & Inflammatory Diseases 🔬

🔗 Read more:
https://t.co/YDVanCLaFE

#Anogen #IL17A #Immunology #Biotech #AutoimmuneDisease #CancerImmunotherapy #MonoclonalAntibody #Cytokines #DrugDevelopment #LifeSciences

[Anogen - Yes Biotech Laboratories Ltd. @AnogenYes]

The latest Antibodies to Watch 2026 report highlights the rapid expansion of antibody-based therapeutics:

Read the full article here: https://t.co/d7VuVfVCWL

#Anogen #Antibodies #Biotech #DrugDevelopment #ADC #Bispecific #Immunotherapy #LifeSciences #Innovation

[Anogen - Yes Biotech Laboratories Ltd. @AnogenYes]

A recent publication from Tiziana Life Sciences highlights the potential of intranasal anti-CD3 therapy (foralumab) in modulating immune responses.

🔗 Read more: https://t.co/DjLuwXXmXo

#Immunotherapy #Neuroinflammation #Cytokines #CAR-T #Biotech
#Anogen

[Anogen - Yes Biotech Laboratories Ltd. @AnogenYes]

Recent data from Tiziana Life Sciences highlights the potential of nasal anti-CD3 therapy (foralumab) in modulating immune responses linked to neuroinflammation and cognitive decline.

📌 Read the full article: https://t.co/l3UxeYAdDT

#Anogen

[Anogen - Yes Biotech Laboratories Ltd. @AnogenYes]

Recent research highlights the potential of intranasal anti-CD3 therapy (foralumab) in patients with non-active secondary progressive multiple sclerosis (na-SPMS).

https://t.co/W4wHmRBYDH

#MultipleSclerosis #Neuroimmunology #Immunotherapy #Biotech #monoclonalantibody
#Anogen

[Anogen - Yes Biotech Laboratories Ltd. @AnogenYes]

🧠 Tau protein plays a key role in neuron stability — but its abnormal buildup is strongly linked to Alzheimer’s disease.
At Anogen, we support studies with recombinant proteins & antibodies for key biomarkers.#Alzheimers #TauProtein #Neuroscience

[Anogen - Yes Biotech Laboratories Ltd. @AnogenYes]

We’re proud to share that our Mouse Interleukin-1β (IL-1β) ELISA Kit (MEC1010) played a key role in a groundbreaking study published in Nature Communications.

Read the full article here: https://t.co/1dh2u6qeUC

https://t.co/s28cbpJ1lD

#InflammationResearch

#Anogen

[Anogen - Yes Biotech Laboratories Ltd. @AnogenYes]

A new study from Washington University School of Medicine reports encouraging evidence that anti-amyloid treatment given before symptoms appear may help delay or prevent Alzheimer’s dementia.

Read more:
https://t.co/iJjHLU6hBy

#Alzheimers #Neuroscience
#Anogen

[Anogen - Yes Biotech Laboratories Ltd. @AnogenYes]

A recent article in Biomedical Research and Therapy explores the role of amyloid-β plaques and tau neurofibrillary tangles in Alzheimer’s disease and the therapeutic strategies targeting these pathologies.

Read the article:

https://t.co/MueI7ddiGE

#AlzheimersDisease

#Anogen

[Anogen - Yes Biotech Laboratories Ltd. @AnogenYes]

New poster data presented at CTAD highlight promising biomarker effects of etalanetug, a tau-targeting immunotherapy.

Read the full article: https://t.co/vYXKMsBHM4

#AlzheimersResearch #Tau #Neurodegeneration #CTAD #Biomarkers #Immunotherapy
#Anogen

[Anogen - Yes Biotech Laboratories Ltd. @AnogenYes]

A study published in Biology Direct reveals how hypoxia influences microglia and promotes glioma growth through inflammatory cytokine secretion
https://t.co/7kBZcQmosY

[Anogen - Yes Biotech Laboratories Ltd. @AnogenYes]

After Tau Immunotherapy, Tangle Markers Tank in CSF, Plasma

Read the full article: https://t.co/kVudqF1cZu

#anogen

[Anogen - Yes Biotech Laboratories Ltd. @AnogenYes]

New research has created a detailed molecular atlas of tau — pinpointing 145 unique modifications and 195 cleavage sites across tauopathies like Alzheimer’s.

Read the full article: https://t.co/qhjTbMdJWZ

#Anogen #Neurology #Neurodegeneration #AlzheimersResearch

[Anogen - Yes Biotech Laboratories Ltd. @AnogenYes]

🧠 Cell highlights how Alzheimer’s therapy is moving beyond amyloid alone—embracing tau targeting, neuroinflammation, and multi-modal strategies to better address disease complexity and drive future breakthroughs. Read the full article: https://t.co/iOldCjrOnP
#Alzheimers #Anogen

[Anogen - Yes Biotech Laboratories Ltd. @AnogenYes]

The investigational anti-tau agent VY7523 showed a favorable safety and tolerability profile in an early Alzheimer’s trial. https://t.co/gptsbWVooq

#Alzheimers #Tau #Neuroscience #ClinicalResearch

[Anogen - Yes Biotech Laboratories Ltd. @AnogenYes]

Anti-amyloid monoclonal antibodies—like lecanemab and donanemab, are changing the landscape of Alzheimer’s disease care by targeting amyloid-β plaques, a core driver of disease.

Read the full article here: https://t.co/yaiBO0m4G8

#AlzheimersResearch #Anogen